Nurix Therapeutics, Inc. (NRIX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$14.74
Day's range
$15.72

Nurix Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 8.93 M $138.35 M   0.57% 8.11%
REDMILE GROUP, LLC 05/15/2026 7.73 M $119.86 M   -4.46% 7.03%
VESTAL POINT CAPITAL, LP 05/15/2026 6.50 M $100.75 M   38.59% 5.91%
DEEP TRACK CAPITAL, LP 05/15/2026 6.35 M $98.35 M   -9.82% 5.76%
FMR LLC 05/15/2026 5.54 M $85.89 M   30.87% 5.03%
STATE STREET CORP 05/15/2026 5.14 M $79.69 M   44.44% 4.67%
MORGAN STANLEY 05/15/2026 4.93 M $76.45 M   1.04% 4.48%
BAKER BROS. ADVISORS LP 05/15/2026 4.66 M $72.21 M   0.00% 4.23%
05/15/2026 4.43 M $68.62 M   100.00% 4.02%
GENERAL ATLANTIC, L.P. 05/15/2026 4.10 M $63.58 M   -16.24% 3.73%
PERCEPTIVE ADVISORS LLC 05/29/2026 3.71 M $57.52 M   4.36% 3.37%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 3.29 M $51.00 M   1.29% 2.99%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 2.73 M $42.26 M   -21.38% 2.48%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.52 M $39.07 M   5.67% 2.29%
RUBRIC CAPITAL MANAGEMENT LP 05/15/2026 2.47 M $38.35 M   0.00% 2.25%
DEUTSCHE BANK AG\ 05/06/2026 2.30 M $35.57 M   -7.71% 2.09%
COMMODORE CAPITAL LP 05/15/2026 2.28 M $35.26 M   0.00% 2.07%
BRAIDWELL LP 05/15/2026 1.75 M $27.14 M   -19.83% 1.59%
05/15/2026 1.74 M $27.02 M   0.00% 1.58%
ARK INVESTMENT MANAGEMENT LLC 05/12/2026 1.72 M $26.68 M   7.40% 1.56%
LONGAEVA PARTNERS L.P. 05/15/2026 1.49 M $23.10 M   60.63% 1.35%
CITADEL ADVISORS LLC 05/15/2026 1.34 M $20.83 M   16.55% 1.22%
GOLDMAN SACHS GROUP INC 05/15/2026 1.32 M $20.44 M   22.37% 1.20%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 1.30 M $20.12 M   0.00% 1.18%
KYNAM CAPITAL MANAGEMENT, LP 05/15/2026 1.19 M $18.52 M   -39.36% 1.09%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 04/30/2026 1.18 M $18.31 M   -8.48% 1.07%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 05/07/2026 1.18 M $18.28 M   -8.48% 1.07%
05/08/2026 1.10 M $17.09 M   100.00% 1.00%
UBS GROUP AG 05/05/2026 976.36 K $15.13 M   130.59% 0.89%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 967.62 K $15.00 M   0.00% 0.88%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 938.16 K $14.54 M   -23.06% 0.85%
WOODLINE PARTNERS LP 05/15/2026 925.44 K $14.34 M   0.00% 0.84%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 924.04 K $14.32 M   -4.33% 0.84%
CAPITAL WORLD INVESTORS 05/13/2026 893.33 K $13.85 M   100.00% 0.81%
NORTHERN TRUST CORP 05/14/2026 854.47 K $13.24 M   6.06% 0.78%
NUVEEN, LLC 04/30/2026 812.60 K $12.60 M   3.59% 0.74%
BANK OF AMERICA CORP /DE/ 05/18/2026 802.15 K $12.43 M   8.91% 0.73%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 780.70 K $12.09 M   81.14% 0.71%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 700.00 K $10.85 M   133.33% 0.64%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 632.23 K $9.80 M   100.00% 0.57%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2026 620.82 K $9.62 M   -15.55% 0.56%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 561.25 K $8.70 M   114.87% 0.51%
HANDELSBANKEN FONDER AB 04/28/2026 547.00 K $8.48 M   0.00% 0.50%
MILLENNIUM MANAGEMENT LLC 05/15/2026 546.30 K $8.47 M   203.91% 0.50%
CANDRIAM S.C.A. 04/30/2026 534.26 K $8.28 M   0.00% 0.49%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 485.21 K $7.52 M   1,766.99% 0.44%
CITIGROUP INC 05/11/2026 477.41 K $7.40 M   179.02% 0.43%
05/15/2026 460.00 K $7.13 M   0.00% 0.42%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 449.11 K $6.96 M   -86.02% 0.41%
FISHER ASSET MANAGEMENT, LLC 05/05/2026 384.83 K $5.96 M   100.00% 0.35%

Nurix Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 239 institutional investors and hedge funds held shares of Nurix Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 8.93 M

Redmile Group, LLC: 7.73 M

Vestal Point Capital, LP: 6.5 M

Deep Track Capital, LP: 6.35 M

FMR LLC: 5.54 M

STATE STREET CORP: 5.14 M

106.32% of Nurix Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 132.46 M shares in the last 24 months. This purchase volume represents approximately $2.05 B in transactions.